People
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The latest biopharma insider trading scandal stems from Pfizer’s acquisition of Medivation in 2016.
Two months after Athira placed its CEO Leen Kawas, on temporary leave, the company has appointed new execs to its team. It is also rigorously advancing its Alzheimer’s program.
Eli Lilly is undertaking a strategic transformation that will result in the formation of new business units.
While treatments exist to manage the symptoms of the disease, nothing has proven to be curative – yet. Several biopharma companies are working hard to change that.
Vivek Ramaswamy is launching a book that represents the social injustice in society. Read the article to get some information about the book and its author.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Aubrey de Grey has been accused by two women of predatory behavior, an allegation de Grey denies. SENS has placed him on administrative leave pending further investigation.
Republican Senator Rand Paul is under fire from government watchdogs for failing to properly disclose a $15,000 purchase of Gilead Sciences stock made by his wife last year.
BioSpace recently spoke with James Oliviero, CEO and president at Checkpoint Therapeutics, an immuno-oncology, late-stage development company.
PRESS RELEASES